A practical approach to gout
- 1 January 1999
- journal article
- Published by Taylor & Francis Ltd in Postgraduate Medicine
- Vol. 106 (4), 115-123
- https://doi.org/10.3810/pgm.1999.10.1.706
Abstract
Gouty arthritis is the culmination of a number of physiologic mechanisms that ultimately result in deposition of uric acid within joints and soft tissues. Decreased uric acid clearance through the kidney is the most common cause of gout. Tophaceous gout occurs in less than 10% of patients. Acute episodes are treated with NSAIDs or colchicine. Low-dose therapy with these agents can also prevent recurrent attacks. Most patients with gout need long-term treatment with either uricosuric agents or xanthine oxidase inhibitors.Keywords
This publication has 11 references indexed in Scilit:
- Gout in the ElderlyDrugs & Aging, 1998
- The Management of GoutThe New England Journal of Medicine, 1996
- Asymptomatic hyperuricemia. Risks and consequences in the normative aging studyThe American Journal of Medicine, 1987
- DIURETIC-INDUCED GOUT IN ELDERLY WOMENRheumatology, 1985
- The efficacy of colchicine prophylaxis in articular gout—A reappraisal after 20 yearsSeminars in Arthritis and Rheumatism, 1982
- Renal outcomes of gout and hyperuricemiaThe American Journal of Medicine, 1979
- Abnormal Urate Excretion Associated with Renal and Systemic Disorders, Drugs, and ToxinsPublished by Springer Science and Business Media LLC ,1978
- Serum uric acid: Its association with other risk factors and with mortality in coronary heart diseaseJournal of Chronic Diseases, 1976
- Regimen of indomethacin therapy in acute gouty arthritis.BMJ, 1967
- Long term uricosuric therapy in goutArthritis & Rheumatism, 1962